BioInsights - Cell therapy bioprocessing - spotlight

CELL & GENE THERAPY INSIGHTS

Cell therapy bioprocessing

Alexey Bersenev
Guest Editor:
Alexey Bersenev, Director, Cell Therapy Processing & Advanced Cell Therapy Labs at Yale University School of Medicine
November 2022
Cell therapy bioprocessing
Download PDF

Commentary

Cell therapy 101 (part 1)Challenges of early clinical development: a ‘thumbnail sketch’

Cell therapy 101 (part 1)Challenges of early clinical development: a ‘thumbnail sketch’

Michael D Leek
29 November 2022
Read

Interview

Advancing cell therapy manufacturing towards industry 4.0

Advancing cell therapy manufacturing towards industry 4.0

Thomas Bollenbach
21 November 2022
Read
Enabling scalable manufacture of exosomes for future clinical & commercial requirements

Enabling scalable manufacture of exosomes for future clinical & commercial requirements

Peter Jones
21 October 2022
Read
Enabling GMP-ready cell sorting for cell and gene therapy manufacturing

Enabling GMP-ready cell sorting for cell and gene therapy manufacturing

Aditi Singh
8 February 2023
Read

Expert Roundtable

AAV process development & scale-up

AAV process development & scale-up

C Cancian, K Doucette, R Hesselink
7 March 2023
Read

FastFacts

A flexible & fully automated process for CAR T cell manufacturing

A flexible & fully automated process for CAR T cell manufacturing

Sophia Lollies
10 November 2022
Read
Standardizing flow cytometric assays during cell manufacturing

Standardizing flow cytometric assays during cell manufacturing

Annika Graband
3 November 2022
Read

Viewpoint

Key considerations for early investment in the process development of cell-based therapeutics

Key considerations for early investment in the process development of cell-based therapeutics

Kelly Kemp, Sebastian Rieck
23 November 2022
Read
Producing cell-based therapeutic products with lot-to-lot consistency from highly variable starting cell products

Producing cell-based therapeutic products with lot-to-lot consistency from highly variable starting cell products

William E Janssen, Scott R Burger
2 November 2022
Read

Webinars

Automating the final cell therapy bioprocess step for robust CMC/GMP compliance

Automating the final cell therapy bioprocess step for robust CMC/GMP compliance

Tracy Moore, Delara Motlagh
11 January 2022
Watch
The next generation of GMP cell sorting - high-throughput, sterile, scalable

The next generation of GMP cell sorting - high-throughput, sterile, scalable

Samson Rogers, PhD
11 October 2022
Watch
Industrialization of cell and gene therapies: process development best practices for commercialization readiness

Industrialization of cell and gene therapies: process development best practices for commercialization readiness

Behnam Baghbaderani
17 November 2022
Watch
Let the cells thrive - The next generation of cell expansion

Let the cells thrive - The next generation of cell expansion

H Fabre, M Barbisin, M Knaub
22 November 2022
Watch
Extracellular Vesicles: From Waste EVictees to Therapeutic Reality

Extracellular Vesicles: From Waste EVictees to Therapeutic Reality

Amy Kauffman
30 November 2022
Watch
How to secure and standardize your cell expansion

How to secure and standardize your cell expansion

Anette Brass, Paula Villaescusa Sánchez
6 December 2022
Watch
Enhancing non-viral genome editing, processing, and expansion of T and NK cells

Enhancing non-viral genome editing, processing, and expansion of T and NK cells

Sung Lee, Deepak Kumar
8 December 2022
Watch